Stock Taper Revenues: $1.04 billion, up 25% year-over-year.
EBITDA: $88.9 million, a 44% increase from Q1 2025, resulting in an EBITDA margin of 8.6%, up 110 basis points.
Backlog: $3.68 billion, a 20% increase from the previous year, with notable growth in both E and M (Electrical and Mechanical) and T and D (Transmission and Distribution) segments.
Operating Cash Flow: $143.7 million, significantly improved from $7.1 million in the prior year.
Free Cash Flow: $131.9 million, up from a cash use of $8.1 million in 2025.
Net Leverage: Pro forma net leverage at approximately 0.5 times post-acquisition of SCNM.
Acquisition: Successful acquisition of SCNM, enhancing ECG's footprint in the Southeast U.S. and diversifying its service offerings, particularly in pharma and healthcare.
Market Trends: Strong demand in diverse markets, particularly data centers, hospitality, and utilities, contributing to backlog growth.
Operational Excellence: Continued focus on disciplined project selection and execution, maintaining a balanced mix of fixed-price and cost-plus contracts to manage risk and margin stability.
2026 Revenue Guidance: Raised to a range of $4.3 billion to $4.4 billion.
EBITDA Guidance: Expected in the range of $345 million to $360 million, with EBITDA margins anticipated around 8.1%.
Seasonality: No significant seasonal dip expected; the company anticipates a more stable revenue pattern throughout the year.
Labor Availability: Ongoing challenges in sourcing qualified labor could constrain growth, despite current strong employment levels.
Market Competition: The competitive landscape remains steady, which could pressure margins and project selection.
Guidance Caution: While the company raised guidance, management expressed caution regarding the timing of project completions and potential normalization of cash flow in future quarters.
Geographic Expansion: Management indicated optimism about securing additional awards in new geographies, particularly with a high-tech client.
Payment Terms: Improved payment terms have positively impacted cash flow, but management noted that the strong cash quarter was largely due to timing rather than a consistent trend.
Contract Mix: The company plans to maintain a balanced approach between fixed-price and cost-plus contracts to manage risks effectively.
Integration of SCNM: Integration is progressing well, and SCNM is expected to contribute significantly to revenue and EBITDA margins in 2026. Overall, ECG reported a strong start to 2026, driven by robust revenue growth and strategic acquisitions, while also highlighting potential challenges in labor availability and market competition.
SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT